{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260416521284/en/Alkermes-to-Present-Additional-Data-From-Vibrance-1-Phase-2-Study-of-Alixorexton-in-Patients-with-Narcolepsy-Type-1-at-the-American-Academy-of-Neurology-AAN-2026-Annual-Meeting", "message": "News view counter 666097 successfully enlarged"}